Seattle Genetics

Developer of antibody-drug conjugates for the treatment of cancer

placeBothell, Washington, United States calendar_todayFounded 1998 groups2,404 employees language seagen.com

Registered entities

Investor mix

13 investors on record; lead investors include Merck, J P Morgan, Baker Brothers Investments; 2 have since exited.

Investor typeCountShare
Venture capital754%
Private equity215%
Bank & private debt18%
Other / undisclosed323%
Coming soon